黄青.重症肺部感染患者外周血调节性T淋巴细胞、白介素10水平与甲泼尼龙疗效的关系[J].内科急危重症杂志,2019,25(1):48-49
扫码阅读全文
|
DOI:10.11768/nkjwzzzz20190115 |
中文关键词: CD4+CD25+调节性T淋巴细胞 白介素10 甲泼尼龙 重症肺部感染 疗效 |
英文关键词: |
基金项目: |
|
摘要点击次数: 1898 |
全文下载次数: 2944 |
中文摘要: |
目的:探讨重症肺部感染(SPI)患者外周血CD4+CD25+调节性T淋巴细胞(Treg)、白介素10(IL-10)水平与甲泼尼龙疗效的关系。方法:选取SPI患者100例作为SPI组,均给予对症治疗和甲泼尼龙治疗,同期选取体检中心健康人员30例作为健康组。结果:SPI组外周血Treg、IL-10水平明显低于健康组(均P<0.05);治疗后,SPI组显效72例(72.0%)、有效20例(20.0%)、无效8例(8.0%);治疗后,显效和有效患者外周血Treg、IL-10水平较治疗前上升(均P<0.05),且显效患者外周血Treg、IL-10水平上升值明显高于有效患者(P<0.05)。结论:外周血Treg、IL-10水平与SPI的发生和转归有关,其水平变化可作为评估甲泼尼龙治疗SPI疗效的重要指标。 |
英文摘要: |
Objective: To discuss the relationship between the peripheral blood CD4 + CD25 + regulatory T lymphocytes (Treg) and interleukin-10 (IL-10) level with efficacy of methylprednisolone in patients with severe pulmonary infection (SPI). Methods: 100 patients with SPI were selected as SPI group, and 30 health persons were selected as healthy group at the same time from the Medical Examination Center. Results: The peripheral blood Treg and IL-10 levels in SPI group were significantly lower than those in healthy group (P< 0.05). After the treatment, 72 cases were excellent (72.00%), 20 cases were valid (20.00%) and 8 cases were invalid (8.00%) in SPI group, and the peripheral blood Treg and IL-10 levels in the patients with excellent and valid efficacy were significantly increased as compared with those before treatment (P<0.05). The peripheral blood Treg and IL-10 levels in the invalid patients before and after treatment showed no statistically significant difference (P>0.05). The increased values of peripheral blood Treg and IL-10 levels in the excellent patients were significantly higher than those in the valid patients, and those in the valid patients were significantly higher than those in the invalid patients (all P<0.05). Conclusions: The peripheral blood Treg and IL-10 levels are related to the occurrence and outcome of SPI. The changes in peripheral blood Treg and IL-10 levels can be used as an important index to evaluate the efficacy of methylprednisone in the treatment of SPI. |
|